NCT02536729

Brief Summary

Objective: The primary objective of this study is to assess the quality of life of people treated with oral phosphate compared with polyethylene glycol + electrolytes to imaging procedures, according to the outcome variables reported by patients. Type of study: A non-interventional observational analytic prospective cohort study. Sample: We will include people who need bowel cleansing for the realization of imaging tests Exposures: - oral sodium phosphate normal regimen

  • Oral sodium phosphate with modified diet
  • Polyethylene Glycol + electrolytes Follow-up time: 8 days after the bowel preparation Outcomes: Boston Scale measure Safety Differences between groups in blood test (Sodium, Potassium, Calcium)

Trial Health

50
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
600

participants targeted

Target at P75+ for all trials

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

August 27, 2015

Completed
5 days until next milestone

First Posted

Study publicly available on registry

September 1, 2015

Completed
Same day until next milestone

Study Start

First participant enrolled

September 1, 2015

Completed
9 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2016

Completed
Last Updated

September 1, 2015

Status Verified

August 1, 2015

Enrollment Period

9 months

First QC Date

August 27, 2015

Last Update Submit

August 31, 2015

Conditions

Outcome Measures

Primary Outcomes (1)

  • Boston scale for bowel cleansing

    2 days

Secondary Outcomes (8)

  • Number of adverse events

    8 days

  • Quality of life

    8 days

  • Blood creatinine

    8 days

  • Blood urea nitrogen (BUN)

    8 days

  • Blood Sodium

    8 days

  • +3 more secondary outcomes

Study Arms (3)

Oral Sodium Phosphate - Normal preparation

Oral sodium phospate exposure with special diet (Liquid)

Drug: Oral Sodium Phosphate - Normal preparation

Oral Sodium Phosphate - Modified preparation

Oral sodium phospate exposure with special diet (Liquid), but the participant can normally lunch the day before the test

Drug: Oral sodium phosphate - Modified Preparation

polyethylene glycol + Electrolytes

polyethylene glycol + Electrolytes exosure with special diet (Liquid)

Drug: polyethylene glycol + Electrolytes

Interventions

Also known as: Travad
Oral Sodium Phosphate - Normal preparation
Also known as: Travad
Oral Sodium Phosphate - Modified preparation
Also known as: PEG
polyethylene glycol + Electrolytes

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Adults who are in diagnostic centers, which have order for an imaging procedure that requires intestinal cleansing conducted.

You may qualify if:

  • Patients which have order for an imaging procedure that requires bowel cleansing
  • Older than 18 years and younger than 65 years old
  • Accept to participate in this study

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Interventions

Polyethylene GlycolsElectrolytes

Intervention Hierarchy (Ancestors)

Ethylene GlycolsGlycolsAlcoholsOrganic ChemicalsPolymersMacromolecular SubstancesBiomedical and Dental MaterialsManufactured MaterialsTechnology, Industry, and AgricultureInorganic Chemicals

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 27, 2015

First Posted

September 1, 2015

Study Start

September 1, 2015

Primary Completion

June 1, 2016

Last Updated

September 1, 2015

Record last verified: 2015-08